Ad-hoc disclosure of June 6, 2021

  • Disclosure of Insider Information as per Article 17 of MAR
  • Wacker Chemie AG / Forecast Change
  • WACKER Raises its Forecast for Fiscal Year 2021

Munich, Jun 16, 2021

Following the sustained positive performance of its business, Wacker Chemie AG (“WACKER”) is raising its full-year guidance for sales and EBITDA. The company now expects full-year 2021 sales of around €5.5 billion (2020: €4.69 billion). Previously, WACKER had assumed sales growth in the low double-digit percentage range. Group EBITDA for 2021 is expected to be between €900 million and €1.1 billion. Previously, WACKER had expected EBITDA to rise by 15 to 25 percent year-on-year (€666 million). For Q2 2021, WACKER expects sales of around €1.5 billion and EBITDA between €300 million and €350 million.

The ongoing positive development of polysilicon prices and the continuously strong demand in WACKER’s chemical business are the reasons for the higher expectations. At the same time, however, higher raw material prices and negative currency effects are expected to weigh on EBITDA with more than €300 million (previous forecast: more than €200 million). The current forecast takes this development into account.


Wacker Chemie AG
Hanns-Seidel-Platz 4
D-81737 München

Jörg Hoffmann
Tel. +49 89 6279-1633

Additional Information

ISIN: DE000WCH8881
Deutsche Boerse : WCH
Ticker Bloomberg CHM/WCK.GR
Ticker Reuters CHE/WCHG.DE
Listing: Frankfurt Stock Exchange (Frankfurter Wertpapierbörse), Official Market (Prime Standard)


This publication contains forward-looking statements based on assumptions and estimates of WACKER’s Executive Board. Although we assume the expectations in these forward-looking statements are realistic, we cannot guarantee they will prove to be correct. The assumptions may harbor risks and uncertainties that may cause the actual figures to differ considerably from the forward-looking statements. Factors that may cause such discrepancies include changes in the economic and business environment, variations in exchange and interest rates, the introduction of competing products, lack of acceptance for new products or services, and changes in corporate strategy. WACKER does not plan to update its forward-looking statements, nor does it assume the obligation to do so.

This document includes supplemental financial measures (not clearly defined in the applicable financial reporting framework) that are or may be alternative performance measures (APM). These supplemental financial measures should not be viewed in isolation or as alternatives to measures of WACKER’s net assets and financial positions or results of operations as presented in accordance with the applicable financial reporting framework in its Consolidated Financial Statements. Other companies that report or describe similarly titled alternative performance measures may calculate them differently. Explanations of financial measures used can be found in the Annual Report of Wacker Chemie AG which is available for download under